

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 3.73582453 |
| 2 | negative regulation of cell killing (GO:0031342) | 3.67706640 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.67706640 |
| 4 | translational termination (GO:0006415) | 3.64632684 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.63357238 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 3.59305172 |
| 7 | DNA deamination (GO:0045006) | 3.51733848 |
| 8 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.47947247 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.45582425 |
| 10 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.42466182 |
| 11 | serine family amino acid catabolic process (GO:0009071) | 3.39985920 |
| 12 | translational elongation (GO:0006414) | 3.39249216 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38123981 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30678589 |
| 15 | cellular response to virus (GO:0098586) | 3.27410946 |
| 16 | transcription from mitochondrial promoter (GO:0006390) | 3.24722207 |
| 17 | translational initiation (GO:0006413) | 3.19244655 |
| 18 | folic acid metabolic process (GO:0046655) | 3.18606736 |
| 19 | nucleotide salvage (GO:0043173) | 3.12519356 |
| 20 | regulation of ARF protein signal transduction (GO:0032012) | 3.12345986 |
| 21 | regulation of cholesterol homeostasis (GO:2000188) | 3.11546991 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.10937199 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10778551 |
| 24 | ribosomal small subunit assembly (GO:0000028) | 3.06143025 |
| 25 | regulation of hippo signaling (GO:0035330) | 3.05021761 |
| 26 | proline biosynthetic process (GO:0006561) | 3.02987622 |
| 27 | glycine metabolic process (GO:0006544) | 3.02782200 |
| 28 | purine nucleotide salvage (GO:0032261) | 3.01223523 |
| 29 | trophectodermal cell differentiation (GO:0001829) | 3.00774202 |
| 30 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.97842727 |
| 31 | positive regulation of Rap GTPase activity (GO:0032854) | 2.96099288 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.95783574 |
| 33 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.94290957 |
| 34 | ribosomal small subunit biogenesis (GO:0042274) | 2.92759466 |
| 35 | protein localization to endosome (GO:0036010) | 2.91725253 |
| 36 | formation of translation preinitiation complex (GO:0001731) | 2.89402410 |
| 37 | regulation of gene silencing by RNA (GO:0060966) | 2.88372453 |
| 38 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.88372453 |
| 39 | regulation of gene silencing by miRNA (GO:0060964) | 2.88372453 |
| 40 | negative regulation of sterol transport (GO:0032372) | 2.86865484 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 2.86865484 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 2.85562578 |
| 43 | embryonic process involved in female pregnancy (GO:0060136) | 2.83005762 |
| 44 | detection of other organism (GO:0098543) | 2.82411599 |
| 45 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.81159894 |
| 46 | homocysteine metabolic process (GO:0050667) | 2.79789186 |
| 47 | regulation of integrin activation (GO:0033623) | 2.77156137 |
| 48 | L-phenylalanine metabolic process (GO:0006558) | 2.76978207 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.76978207 |
| 50 | sodium ion export (GO:0071436) | 2.74460581 |
| 51 | maternal placenta development (GO:0001893) | 2.73168274 |
| 52 | regulation of early endosome to late endosome transport (GO:2000641) | 2.73167677 |
| 53 | cysteine metabolic process (GO:0006534) | 2.72950853 |
| 54 | flavonoid metabolic process (GO:0009812) | 2.72772647 |
| 55 | positive regulation of receptor recycling (GO:0001921) | 2.70793594 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 2.70438210 |
| 57 | positive regulation by symbiont of host defense response (GO:0052509) | 2.68724020 |
| 58 | modulation by symbiont of host defense response (GO:0052031) | 2.68724020 |
| 59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68724020 |
| 60 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.68724020 |
| 61 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.68724020 |
| 62 | modulation by symbiont of host immune response (GO:0052553) | 2.68724020 |
| 63 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.68511183 |
| 64 | proline metabolic process (GO:0006560) | 2.67778567 |
| 65 | barbed-end actin filament capping (GO:0051016) | 2.65805420 |
| 66 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.65760669 |
| 67 | cellular protein complex disassembly (GO:0043624) | 2.65307062 |
| 68 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.65251709 |
| 69 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.65088684 |
| 70 | viral life cycle (GO:0019058) | 2.64705302 |
| 71 | detection of bacterium (GO:0016045) | 2.64229427 |
| 72 | signal complex assembly (GO:0007172) | 2.64214567 |
| 73 | hypotonic response (GO:0006971) | 2.61498633 |
| 74 | mitotic G1/S transition checkpoint (GO:0044819) | 2.59464528 |
| 75 | detection of external biotic stimulus (GO:0098581) | 2.59103941 |
| 76 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.58429625 |
| 77 | intestinal cholesterol absorption (GO:0030299) | 2.57568224 |
| 78 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.57290839 |
| 79 | stress fiber assembly (GO:0043149) | 2.56961477 |
| 80 | protein targeting to ER (GO:0045047) | 2.56291691 |
| 81 | response to laminar fluid shear stress (GO:0034616) | 2.53602887 |
| 82 | cellular potassium ion homeostasis (GO:0030007) | 2.53237970 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 2.52698255 |
| 84 | kynurenine metabolic process (GO:0070189) | 2.52380421 |
| 85 | ribosome biogenesis (GO:0042254) | 2.51622778 |
| 86 | positive regulation of T cell apoptotic process (GO:0070234) | 2.51305776 |
| 87 | 4-hydroxyproline metabolic process (GO:0019471) | 2.51202086 |
| 88 | positive regulation of lipid storage (GO:0010884) | 2.50393381 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.49184060 |
| 90 | cotranslational protein targeting to membrane (GO:0006613) | 2.48925711 |
| 91 | actin filament polymerization (GO:0030041) | 2.48765583 |
| 92 | regulation of Rap GTPase activity (GO:0032317) | 2.48051279 |
| 93 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.47786017 |
| 94 | G1 DNA damage checkpoint (GO:0044783) | 2.46886031 |
| 95 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.46795717 |
| 96 | mitotic metaphase plate congression (GO:0007080) | 2.45595785 |
| 97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.44321325 |
| 98 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.43898859 |
| 99 | macroautophagy (GO:0016236) | 2.42837792 |
| 100 | intestinal absorption (GO:0050892) | 2.42714132 |
| 101 | phospholipid efflux (GO:0033700) | 2.41979554 |
| 102 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.41059879 |
| 103 | positive regulation of protein homooligomerization (GO:0032464) | 2.39667360 |
| 104 | regulation of translational termination (GO:0006449) | 2.38381904 |
| 105 | regulation of histone phosphorylation (GO:0033127) | 2.37996839 |
| 106 | protein complex disassembly (GO:0043241) | 2.37381881 |
| 107 | urate metabolic process (GO:0046415) | 2.37088762 |
| 108 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.37057375 |
| 109 | cellular response to catecholamine stimulus (GO:0071870) | 2.36989648 |
| 110 | cellular response to monoamine stimulus (GO:0071868) | 2.36989648 |
| 111 | regulation of cholesterol metabolic process (GO:0090181) | 2.36609965 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 2.35827896 |
| 113 | lysine metabolic process (GO:0006553) | 2.34529619 |
| 114 | lysine catabolic process (GO:0006554) | 2.34529619 |
| 115 | protein localization to endoplasmic reticulum (GO:0070972) | 2.34459731 |
| 116 | cerebellar granule cell differentiation (GO:0021707) | 2.34004854 |
| 117 | maturation of SSU-rRNA (GO:0030490) | 2.32365018 |
| 118 | nucleoside salvage (GO:0043174) | 2.31927865 |
| 119 | inner cell mass cell proliferation (GO:0001833) | 2.31320781 |
| 120 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.31241619 |
| 121 | leukocyte apoptotic process (GO:0071887) | 2.31077555 |
| 122 | regulation of ARF GTPase activity (GO:0032312) | 2.30537604 |
| 123 | regulation of extracellular matrix disassembly (GO:0010715) | 2.30506735 |
| 124 | interferon-gamma secretion (GO:0072643) | 2.29096411 |
| 125 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.28678253 |
| 126 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.28641885 |
| 127 | urea metabolic process (GO:0019627) | 2.28178765 |
| 128 | urea cycle (GO:0000050) | 2.28178765 |
| 129 | mannose metabolic process (GO:0006013) | 2.28154586 |
| 130 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.27969740 |
| 131 | T cell apoptotic process (GO:0070231) | 2.27595301 |
| 132 | tryptophan metabolic process (GO:0006568) | 2.27589200 |
| 133 | cortical actin cytoskeleton organization (GO:0030866) | 2.27202254 |
| 134 | ribosomal large subunit biogenesis (GO:0042273) | 2.27066115 |
| 135 | negative regulation of fatty acid transport (GO:2000192) | 2.26460571 |
| 136 | negative regulation of type 2 immune response (GO:0002829) | 2.26449019 |
| 137 | replication fork processing (GO:0031297) | 2.25440762 |
| 138 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.25069092 |
| 139 | regulation of lipid kinase activity (GO:0043550) | 2.25045350 |
| 140 | mitochondrial DNA metabolic process (GO:0032042) | 2.24509629 |
| 141 | virion attachment to host cell (GO:0019062) | 2.23305480 |
| 142 | adhesion of symbiont to host cell (GO:0044650) | 2.23305480 |
| 143 | tryptophan catabolic process (GO:0006569) | 2.23286677 |
| 144 | indole-containing compound catabolic process (GO:0042436) | 2.23286677 |
| 145 | indolalkylamine catabolic process (GO:0046218) | 2.23286677 |
| 146 | protein retention in ER lumen (GO:0006621) | 2.22951053 |
| 147 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.22470365 |
| 148 | cellular glucuronidation (GO:0052695) | 2.22121858 |
| 149 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.21852037 |
| 150 | amino-acid betaine metabolic process (GO:0006577) | 2.21409998 |
| 151 | modulation by symbiont of host cellular process (GO:0044068) | 2.20666564 |
| 152 | lipoprotein transport (GO:0042953) | 2.19437722 |
| 153 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.19212103 |
| 154 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.19083685 |
| 155 | positive regulation of protein dephosphorylation (GO:0035307) | 2.18958042 |
| 156 | drug catabolic process (GO:0042737) | 2.18409008 |
| 157 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.18111476 |
| 158 | negative regulation of inclusion body assembly (GO:0090084) | 2.17688021 |
| 159 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.17596640 |
| 160 | adenosine receptor signaling pathway (GO:0001973) | 2.16523605 |
| 161 | positive regulation of lipid kinase activity (GO:0090218) | 2.16213485 |
| 162 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.13854087 |
| 163 | detection of biotic stimulus (GO:0009595) | 2.13764071 |
| 164 | cortical cytoskeleton organization (GO:0030865) | 2.13370977 |
| 165 | angiotensin maturation (GO:0002003) | 2.13244650 |
| 166 | cellular response to epinephrine stimulus (GO:0071872) | 2.11558381 |
| 167 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.11222788 |
| 168 | cell communication by electrical coupling (GO:0010644) | 2.11119832 |
| 169 | positive regulation of myotube differentiation (GO:0010831) | 2.09424280 |
| 170 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.08945819 |
| 171 | regulation of leukocyte degranulation (GO:0043300) | 2.07844866 |
| 172 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.07340997 |
| 173 | regulation of macrophage cytokine production (GO:0010935) | 2.06782017 |
| 174 | response to nerve growth factor (GO:1990089) | 2.06156883 |
| 175 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.06156883 |
| 176 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.05853348 |
| 177 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.05727931 |
| 178 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.05225444 |
| 179 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.05003228 |
| 180 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.04475943 |
| 181 | negative regulation of myotube differentiation (GO:0010832) | 2.04077397 |
| 182 | activation of JUN kinase activity (GO:0007257) | 2.02823169 |
| 183 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.00794411 |
| 184 | regulation of extracellular matrix organization (GO:1903053) | 1.99852625 |
| 185 | focal adhesion assembly (GO:0048041) | 1.99528928 |
| 186 | cell-substrate adherens junction assembly (GO:0007045) | 1.99528928 |
| 187 | response to fluid shear stress (GO:0034405) | 1.99422428 |
| 188 | negative regulation of small GTPase mediated signal transduction (GO:0051058) | 1.97925525 |
| 189 | response to peptidoglycan (GO:0032494) | 1.97381666 |
| 190 | regulation of regulated secretory pathway (GO:1903305) | 1.97121435 |
| 191 | regulation of necroptotic process (GO:0060544) | 1.94579481 |
| 192 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 1.94353239 |
| 193 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.92772158 |
| 194 | positive thymic T cell selection (GO:0045059) | 1.92674914 |
| 195 | Rap protein signal transduction (GO:0032486) | 1.92455994 |
| 196 | negative regulation of granulocyte differentiation (GO:0030853) | 1.91919129 |
| 197 | macrophage activation (GO:0042116) | 1.91715995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.03318007 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.87130225 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.60032190 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.57485369 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.53161450 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46416887 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42075656 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.36549481 |
| 9 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.24736624 |
| 10 | KDM2B_26808549_Chip-Seq_K562_Human | 2.19436830 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.16916976 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.11888623 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.10325162 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.10136530 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.94346651 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94345544 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91888261 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.87248671 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.86779099 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79627476 |
| 21 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.76744861 |
| 22 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.76631363 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73627709 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.73200355 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.66959972 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66198596 |
| 27 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.66047799 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64255706 |
| 29 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.59202888 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58199095 |
| 31 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.57436331 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57180891 |
| 33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.56684908 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55913154 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55067119 |
| 36 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54285832 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52393270 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.51735752 |
| 39 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.47957451 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46714839 |
| 41 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45801239 |
| 42 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.45765427 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45709490 |
| 44 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.45649504 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44156938 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43776911 |
| 47 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.42918442 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.40613453 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.39948445 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.39719532 |
| 51 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.38467413 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38129328 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37066220 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37023225 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36432903 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.35772974 |
| 57 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.35373129 |
| 58 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33350380 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.32489053 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32186116 |
| 61 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.31221752 |
| 62 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.31056922 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31040839 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30897274 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30822122 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29647852 |
| 67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29524614 |
| 68 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.29511403 |
| 69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29313750 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28377928 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27800103 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27214023 |
| 73 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.24591234 |
| 74 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24529087 |
| 75 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24251500 |
| 76 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24034450 |
| 77 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24034450 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23853157 |
| 79 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23479779 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22389231 |
| 81 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.22161001 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22134361 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21667343 |
| 84 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21450241 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21298473 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21215622 |
| 87 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20976208 |
| 88 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.20722583 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.20669250 |
| 90 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20480594 |
| 91 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18410686 |
| 92 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18392159 |
| 93 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18392159 |
| 94 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18330030 |
| 95 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17728013 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17429585 |
| 97 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16778025 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.16619911 |
| 99 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.16511002 |
| 100 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.16214408 |
| 101 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16109505 |
| 102 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15690302 |
| 103 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.15096801 |
| 104 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.15046477 |
| 105 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14531076 |
| 106 | MAF_26560356_Chip-Seq_TH1_Human | 1.13729952 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13574664 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13362629 |
| 109 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13235295 |
| 110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12517969 |
| 111 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.12192722 |
| 112 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11663379 |
| 113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11046704 |
| 114 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11038041 |
| 115 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.11016743 |
| 116 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.09985471 |
| 117 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09852639 |
| 118 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09245411 |
| 119 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09211657 |
| 120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08435276 |
| 121 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08174131 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 1.07013990 |
| 123 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06670503 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05795856 |
| 125 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05790045 |
| 126 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05669874 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05639144 |
| 128 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04864959 |
| 129 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04864959 |
| 130 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04864959 |
| 131 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04601653 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04545457 |
| 133 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.03923353 |
| 134 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03592019 |
| 135 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03561494 |
| 136 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03498253 |
| 137 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03231030 |
| 138 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02401901 |
| 139 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02352063 |
| 140 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02332837 |
| 141 | P68_20966046_ChIP-Seq_HELA_Human | 1.02032322 |
| 142 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01997558 |
| 143 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01393743 |
| 144 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00941699 |
| 145 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00899873 |
| 146 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00706006 |
| 147 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00669124 |
| 148 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00326480 |
| 149 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00144867 |
| 150 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.00086981 |
| 151 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99869199 |
| 152 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99651171 |
| 153 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99431748 |
| 154 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98977520 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98751652 |
| 156 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98412420 |
| 157 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98286441 |
| 158 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.98042448 |
| 159 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96832500 |
| 160 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96812207 |
| 161 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96266147 |
| 162 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95973614 |
| 163 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.95902659 |
| 164 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95131969 |
| 165 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95025114 |
| 166 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94886828 |
| 167 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94672874 |
| 168 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94465307 |
| 169 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93964879 |
| 170 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93803259 |
| 171 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.93739237 |
| 172 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92586696 |
| 173 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92342776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.00782559 |
| 2 | MP0005409_darkened_coat_color | 3.74661013 |
| 3 | MP0009840_abnormal_foam_cell | 3.46676532 |
| 4 | MP0005360_urolithiasis | 3.40215633 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.16018791 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.84876248 |
| 7 | MP0003693_abnormal_embryo_hatching | 2.79279534 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.64060231 |
| 9 | MP0003646_muscle_fatigue | 2.62954623 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.51341464 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.49866334 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.47318863 |
| 13 | MP0003724_increased_susceptibility_to | 2.38102884 |
| 14 | MP0005365_abnormal_bile_salt | 2.38003889 |
| 15 | MP0001958_emphysema | 2.30657731 |
| 16 | MP0005083_abnormal_biliary_tract | 2.24487909 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.22685605 |
| 18 | MP0005451_abnormal_body_composition | 2.22630305 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.19876788 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.08625925 |
| 21 | MP0008260_abnormal_autophagy | 2.08572111 |
| 22 | MP0003690_abnormal_glial_cell | 2.03696472 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.89088922 |
| 24 | MP0003279_aneurysm | 1.87644734 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.85043931 |
| 26 | MP0003091_abnormal_cell_migration | 1.75545675 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 1.70675392 |
| 28 | MP0003878_abnormal_ear_physiology | 1.70675392 |
| 29 | MP0005275_abnormal_skin_tensile | 1.68549452 |
| 30 | MP0003941_abnormal_skin_development | 1.66737173 |
| 31 | MP0003879_abnormal_hair_cell | 1.62307693 |
| 32 | MP0009278_abnormal_bone_marrow | 1.59862519 |
| 33 | MP0003329_amyloid_beta_deposits | 1.55718285 |
| 34 | MP0003283_abnormal_digestive_organ | 1.52328175 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.51358595 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.51358595 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.47273604 |
| 38 | MP0000609_abnormal_liver_physiology | 1.44939932 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.44146599 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.41907371 |
| 41 | MP0004859_abnormal_synaptic_plasticity | 1.41676084 |
| 42 | MP0003111_abnormal_nucleus_morphology | 1.40250116 |
| 43 | MP0002971_abnormal_brown_adipose | 1.35393280 |
| 44 | MP0003718_maternal_effect | 1.34660184 |
| 45 | MP0001730_embryonic_growth_arrest | 1.33357740 |
| 46 | MP0003186_abnormal_redox_activity | 1.32190625 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.30937453 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.29705409 |
| 49 | MP0002822_catalepsy | 1.29322825 |
| 50 | MP0000751_myopathy | 1.25780389 |
| 51 | MP0003453_abnormal_keratinocyte_physiol | 1.24055562 |
| 52 | MP0001851_eye_inflammation | 1.23866847 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.22194241 |
| 54 | MP0005332_abnormal_amino_acid | 1.21834745 |
| 55 | MP0001188_hyperpigmentation | 1.21664461 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 1.20763643 |
| 57 | MP0002896_abnormal_bone_mineralization | 1.19431615 |
| 58 | MP0010329_abnormal_lipoprotein_level | 1.18740729 |
| 59 | MP0005257_abnormal_intraocular_pressure | 1.18575117 |
| 60 | MP0005025_abnormal_response_to | 1.18282652 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.17752015 |
| 62 | MP0003077_abnormal_cell_cycle | 1.17645482 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.16614154 |
| 64 | MP0000920_abnormal_myelination | 1.16155777 |
| 65 | MP0001849_ear_inflammation | 1.15940120 |
| 66 | MP0002419_abnormal_innate_immunity | 1.15751138 |
| 67 | MP0000604_amyloidosis | 1.15498501 |
| 68 | MP0005375_adipose_tissue_phenotype | 1.15302196 |
| 69 | MP0000490_abnormal_crypts_of | 1.15054539 |
| 70 | MP0010307_abnormal_tumor_latency | 1.11205524 |
| 71 | MP0005166_decreased_susceptibility_to | 1.11123205 |
| 72 | MP0003252_abnormal_bile_duct | 1.11046224 |
| 73 | MP0001666_abnormal_nutrient_absorption | 1.10918308 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.10775528 |
| 75 | MP0005380_embryogenesis_phenotype | 1.09345481 |
| 76 | MP0001672_abnormal_embryogenesis/_devel | 1.09345481 |
| 77 | MP0002796_impaired_skin_barrier | 1.09119863 |
| 78 | MP0004510_myositis | 1.08710374 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.07914960 |
| 80 | MP0002086_abnormal_extraembryonic_tissu | 1.07267182 |
| 81 | MP0002653_abnormal_ependyma_morphology | 1.05811036 |
| 82 | MP0005503_abnormal_tendon_morphology | 1.04995014 |
| 83 | MP0003303_peritoneal_inflammation | 1.04032009 |
| 84 | MP0003984_embryonic_growth_retardation | 1.03838933 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 1.03073061 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 1.02631014 |
| 87 | MP0004883_abnormal_blood_vessel | 1.01974423 |
| 88 | MP0006082_CNS_inflammation | 1.01729315 |
| 89 | MP0000462_abnormal_digestive_system | 1.01717244 |
| 90 | MP0002088_abnormal_embryonic_growth/wei | 1.01351332 |
| 91 | MP0005666_abnormal_adipose_tissue | 1.01028682 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.99297459 |
| 93 | MP0003866_abnormal_defecation | 0.98583772 |
| 94 | MP0000598_abnormal_liver_morphology | 0.98370882 |
| 95 | MP0004947_skin_inflammation | 0.97285948 |
| 96 | MP0001790_abnormal_immune_system | 0.96641280 |
| 97 | MP0005387_immune_system_phenotype | 0.96641280 |
| 98 | MP0001697_abnormal_embryo_size | 0.96110923 |
| 99 | MP0003123_paternal_imprinting | 0.95820949 |
| 100 | MP0008874_decreased_physiological_sensi | 0.95678700 |
| 101 | MP0000747_muscle_weakness | 0.94930541 |
| 102 | MP0000750_abnormal_muscle_regeneration | 0.94570029 |
| 103 | MP0002269_muscular_atrophy | 0.93464108 |
| 104 | MP0000685_abnormal_immune_system | 0.93392913 |
| 105 | MP0005388_respiratory_system_phenotype | 0.92481110 |
| 106 | MP0002133_abnormal_respiratory_system | 0.92481110 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.92235191 |
| 108 | MP0005381_digestive/alimentary_phenotyp | 0.92229297 |
| 109 | MP0003634_abnormal_glial_cell | 0.91173744 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.90129257 |
| 111 | MP0000759_abnormal_skeletal_muscle | 0.89073751 |
| 112 | MP0008569_lethality_at_weaning | 0.87747714 |
| 113 | MP0000858_altered_metastatic_potential | 0.87696298 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.87253939 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.86822350 |
| 116 | MP0006138_congestive_heart_failure | 0.86698251 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.86004660 |
| 118 | MP0001663_abnormal_digestive_system | 0.85846914 |
| 119 | MP0008004_abnormal_stomach_pH | 0.85845503 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.84987331 |
| 121 | MP0005164_abnormal_response_to | 0.84866304 |
| 122 | MP0003436_decreased_susceptibility_to | 0.83897417 |
| 123 | MP0009115_abnormal_fat_cell | 0.82696028 |
| 124 | MP0005501_abnormal_skin_physiology | 0.82552547 |
| 125 | MP0003075_altered_response_to | 0.82551232 |
| 126 | MP0003828_pulmonary_edema | 0.82376330 |
| 127 | MP0002019_abnormal_tumor_incidence | 0.82052466 |
| 128 | MP0004858_abnormal_nervous_system | 0.81773125 |
| 129 | MP0000350_abnormal_cell_proliferation | 0.81382746 |
| 130 | MP0002080_prenatal_lethality | 0.80940264 |
| 131 | MP0002085_abnormal_embryonic_tissue | 0.80823980 |
| 132 | MP0000733_abnormal_muscle_development | 0.80762942 |
| 133 | MP0002138_abnormal_hepatobiliary_system | 0.80576811 |
| 134 | MP0004197_abnormal_fetal_growth/weight/ | 0.80561085 |
| 135 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79422575 |
| 136 | MP0010630_abnormal_cardiac_muscle | 0.78785294 |
| 137 | MP0005023_abnormal_wound_healing | 0.78329133 |
| 138 | MP0005390_skeleton_phenotype | 0.78061504 |
| 139 | MP0002006_tumorigenesis | 0.76633135 |
| 140 | MP0001835_abnormal_antigen_presentation | 0.76578340 |
| 141 | MP0004087_abnormal_muscle_fiber | 0.76524071 |
| 142 | MP0010155_abnormal_intestine_physiology | 0.76216538 |
| 143 | MP0002084_abnormal_developmental_patter | 0.75979333 |
| 144 | MP0005330_cardiomyopathy | 0.75279539 |
| 145 | MP0009785_altered_susceptibility_to | 0.75252195 |
| 146 | MP0005058_abnormal_lysosome_morphology | 0.74655031 |
| 147 | MP0008932_abnormal_embryonic_tissue | 0.74297701 |
| 148 | MP0002277_abnormal_respiratory_mucosa | 0.73851659 |
| 149 | MP0004270_analgesia | 0.73761672 |
| 150 | MP0004808_abnormal_hematopoietic_stem | 0.73605893 |
| 151 | MP0005464_abnormal_platelet_physiology | 0.73486448 |
| 152 | MP0003656_abnormal_erythrocyte_physiolo | 0.72832387 |
| 153 | MP0010094_abnormal_chromosome_stability | 0.72515700 |
| 154 | MP0000343_altered_response_to | 0.71535577 |
| 155 | MP0000767_abnormal_smooth_muscle | 0.70867990 |
| 156 | MP0001800_abnormal_humoral_immune | 0.70110256 |
| 157 | MP0000477_abnormal_intestine_morphology | 0.69961393 |
| 158 | MP0000534_abnormal_ureter_morphology | 0.69602196 |
| 159 | MP0000013_abnormal_adipose_tissue | 0.69224259 |
| 160 | MP0002166_altered_tumor_susceptibility | 0.69054003 |
| 161 | MP0005408_hypopigmentation | 0.68738795 |
| 162 | MP0005535_abnormal_body_temperature | 0.68723520 |
| 163 | MP0000313_abnormal_cell_death | 0.68198835 |
| 164 | MP0005623_abnormal_meninges_morphology | 0.68127630 |
| 165 | MP0002249_abnormal_larynx_morphology | 0.66760918 |
| 166 | MP0004130_abnormal_muscle_cell | 0.66305845 |
| 167 | MP0003172_abnormal_lysosome_physiology | 0.65452931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Polycythemia (HP:0001901) | 4.53684837 |
| 2 | Multiple enchondromatosis (HP:0005701) | 3.87944156 |
| 3 | Obstructive sleep apnea (HP:0002870) | 3.46911086 |
| 4 | Hyperglycinemia (HP:0002154) | 3.18053813 |
| 5 | Hyperglycinuria (HP:0003108) | 3.16090448 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.04530701 |
| 7 | Abnormal cartilage morphology (HP:0002763) | 3.03107662 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.86850475 |
| 9 | Xanthomatosis (HP:0000991) | 2.85428038 |
| 10 | Thin bony cortex (HP:0002753) | 2.80050930 |
| 11 | Protrusio acetabuli (HP:0003179) | 2.79349463 |
| 12 | Progressive muscle weakness (HP:0003323) | 2.76625197 |
| 13 | Increased variability in muscle fiber diameter (HP:0003557) | 2.75273153 |
| 14 | Deep venous thrombosis (HP:0002625) | 2.72461514 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 2.65411068 |
| 16 | Gout (HP:0001997) | 2.64823549 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 2.63378264 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.63378264 |
| 19 | Abnormality of the 1st metacarpal (HP:0010009) | 2.61703680 |
| 20 | Hyperammonemia (HP:0001987) | 2.61002608 |
| 21 | Tetraparesis (HP:0002273) | 2.60775302 |
| 22 | Aortic aneurysm (HP:0004942) | 2.59132179 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58781916 |
| 24 | Difficulty running (HP:0009046) | 2.55976994 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 2.54540822 |
| 26 | Gingivitis (HP:0000230) | 2.52789640 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51475313 |
| 28 | Peritonitis (HP:0002586) | 2.48737524 |
| 29 | Hypochromic anemia (HP:0001931) | 2.48149998 |
| 30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.46902203 |
| 31 | Breech presentation (HP:0001623) | 2.45911630 |
| 32 | Intrahepatic cholestasis (HP:0001406) | 2.42108477 |
| 33 | Hyporeflexia of lower limbs (HP:0002600) | 2.40644004 |
| 34 | Myocardial infarction (HP:0001658) | 2.38860048 |
| 35 | Syringomyelia (HP:0003396) | 2.36092856 |
| 36 | Spinal cord lesions (HP:0100561) | 2.36092856 |
| 37 | Increased serum ferritin (HP:0003281) | 2.34822249 |
| 38 | Hypercortisolism (HP:0001578) | 2.34574928 |
| 39 | Recurrent abscess formation (HP:0002722) | 2.34099173 |
| 40 | Cellulitis (HP:0100658) | 2.33251580 |
| 41 | Nausea (HP:0002018) | 2.31114160 |
| 42 | Hyperparathyroidism (HP:0000843) | 2.26942157 |
| 43 | Vascular tortuosity (HP:0004948) | 2.25844085 |
| 44 | Abnormality of the Achilles tendon (HP:0005109) | 2.23492720 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.23374297 |
| 46 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.19461519 |
| 47 | Spastic paraparesis (HP:0002313) | 2.19120338 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18649844 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.18566417 |
| 50 | Cupped ribs (HP:0000887) | 2.18016104 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.17830859 |
| 52 | Flat acetabular roof (HP:0003180) | 2.17523737 |
| 53 | Papilledema (HP:0001085) | 2.17434935 |
| 54 | Difficulty climbing stairs (HP:0003551) | 2.14515874 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.12732495 |
| 56 | Abnormality of the aortic arch (HP:0012303) | 2.11830417 |
| 57 | Patellar aplasia (HP:0006443) | 2.11140764 |
| 58 | Arterial tortuosity (HP:0005116) | 2.10549160 |
| 59 | Asymmetric septal hypertrophy (HP:0001670) | 2.10339327 |
| 60 | Facial hemangioma (HP:0000329) | 2.10007429 |
| 61 | Late onset (HP:0003584) | 2.09328133 |
| 62 | Cerebral aneurysm (HP:0004944) | 2.08074077 |
| 63 | Exercise-induced myalgia (HP:0003738) | 2.07613915 |
| 64 | Pustule (HP:0200039) | 2.07400866 |
| 65 | Atrioventricular block (HP:0001678) | 2.07316734 |
| 66 | Achilles tendon contracture (HP:0001771) | 2.04049693 |
| 67 | Muscle fibrillation (HP:0010546) | 2.04013205 |
| 68 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.03968953 |
| 69 | Malnutrition (HP:0004395) | 2.03769423 |
| 70 | Broad metatarsal (HP:0001783) | 2.03455072 |
| 71 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.03403119 |
| 72 | Abnormal hemoglobin (HP:0011902) | 2.03127777 |
| 73 | Hematochezia (HP:0002573) | 2.03065762 |
| 74 | Overlapping toe (HP:0001845) | 2.02995919 |
| 75 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.01384862 |
| 76 | Abnormality of complement system (HP:0005339) | 2.01363812 |
| 77 | Aneurysm (HP:0002617) | 2.00155163 |
| 78 | Hypolipoproteinemia (HP:0010981) | 2.00119466 |
| 79 | Mitral regurgitation (HP:0001653) | 1.99444489 |
| 80 | Spontaneous hematomas (HP:0007420) | 1.98104433 |
| 81 | Esophageal varix (HP:0002040) | 1.97404006 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97264717 |
| 83 | Dilatation of the ascending aorta (HP:0005111) | 1.97052836 |
| 84 | Supranuclear gaze palsy (HP:0000605) | 1.96700696 |
| 85 | Ketosis (HP:0001946) | 1.95890772 |
| 86 | Hand muscle atrophy (HP:0009130) | 1.95027008 |
| 87 | Adenoma sebaceum (HP:0009720) | 1.94187076 |
| 88 | Angiofibromas (HP:0010615) | 1.94187076 |
| 89 | Amyloidosis (HP:0011034) | 1.93047166 |
| 90 | Shawl scrotum (HP:0000049) | 1.92175882 |
| 91 | Cerebral inclusion bodies (HP:0100314) | 1.91787600 |
| 92 | Action tremor (HP:0002345) | 1.91688776 |
| 93 | Muscle fiber splitting (HP:0003555) | 1.90494703 |
| 94 | Petechiae (HP:0000967) | 1.90014606 |
| 95 | Emphysema (HP:0002097) | 1.89990798 |
| 96 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.89989065 |
| 97 | Overgrowth (HP:0001548) | 1.88530124 |
| 98 | Ventricular tachycardia (HP:0004756) | 1.87345923 |
| 99 | Mitral valve prolapse (HP:0001634) | 1.86571482 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.86502117 |
| 101 | Vertebral compression fractures (HP:0002953) | 1.85362455 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 1.85094314 |
| 103 | Myoglobinuria (HP:0002913) | 1.84507342 |
| 104 | Axonal loss (HP:0003447) | 1.82645999 |
| 105 | Mitral stenosis (HP:0001718) | 1.82480368 |
| 106 | Abnormality of macrophages (HP:0004311) | 1.82286464 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81554885 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 1.81523568 |
| 109 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.81463467 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.80368369 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 1.80368369 |
| 112 | Aortic dissection (HP:0002647) | 1.80169270 |
| 113 | Increased IgE level (HP:0003212) | 1.78216863 |
| 114 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.77036107 |
| 115 | Tongue fasciculations (HP:0001308) | 1.76832386 |
| 116 | Hypoalphalipoproteinemia (HP:0003233) | 1.76740009 |
| 117 | Turricephaly (HP:0000262) | 1.76677331 |
| 118 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.76501827 |
| 119 | Abnormal vertebral ossification (HP:0100569) | 1.75595216 |
| 120 | Rapidly progressive (HP:0003678) | 1.74983571 |
| 121 | Abnormality of purine metabolism (HP:0004352) | 1.74673091 |
| 122 | Ventricular fibrillation (HP:0001663) | 1.74579058 |
| 123 | Carpal bone hypoplasia (HP:0001498) | 1.74086912 |
| 124 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.73836037 |
| 125 | Abnormality of nucleobase metabolism (HP:0010932) | 1.72982237 |
| 126 | Eczematoid dermatitis (HP:0000976) | 1.72784294 |
| 127 | Upper limb amyotrophy (HP:0009129) | 1.72657479 |
| 128 | Distal upper limb amyotrophy (HP:0007149) | 1.72657479 |
| 129 | Short phalanx of the thumb (HP:0009660) | 1.72178021 |
| 130 | Abnormal delivery (HP:0001787) | 1.71817258 |
| 131 | Ketoacidosis (HP:0001993) | 1.71376164 |
| 132 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70914111 |
| 133 | Abnormality of the nasal mucosa (HP:0000433) | 1.70428333 |
| 134 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.69600530 |
| 135 | Hypoglycemic coma (HP:0001325) | 1.69321443 |
| 136 | Hyperextensible skin (HP:0000974) | 1.68811748 |
| 137 | Ankle clonus (HP:0011448) | 1.68783958 |
| 138 | Long toe (HP:0010511) | 1.68280275 |
| 139 | Distal lower limb muscle weakness (HP:0009053) | 1.68076107 |
| 140 | Abnormality of lateral ventricle (HP:0030047) | 1.67313226 |
| 141 | Orchitis (HP:0100796) | 1.67022153 |
| 142 | Bundle branch block (HP:0011710) | 1.66801243 |
| 143 | Shallow orbits (HP:0000586) | 1.66795075 |
| 144 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.66644658 |
| 145 | Thoracolumbar scoliosis (HP:0002944) | 1.66128122 |
| 146 | Fragile skin (HP:0001030) | 1.66005645 |
| 147 | Breast hypoplasia (HP:0003187) | 1.65998460 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.65972536 |
| 149 | Abnormality of proline metabolism (HP:0010907) | 1.65972536 |
| 150 | Areflexia of lower limbs (HP:0002522) | 1.65763612 |
| 151 | Distal lower limb amyotrophy (HP:0008944) | 1.65660044 |
| 152 | Fat malabsorption (HP:0002630) | 1.65452928 |
| 153 | Abnormality of the fingertips (HP:0001211) | 1.64719480 |
| 154 | Abnormal number of erythroid precursors (HP:0012131) | 1.64093921 |
| 155 | Growth hormone excess (HP:0000845) | 1.63301120 |
| 156 | Exercise-induced muscle cramps (HP:0003710) | 1.63146690 |
| 157 | Abnormality of the foot musculature (HP:0001436) | 1.63006108 |
| 158 | Autoimmune thrombocytopenia (HP:0001973) | 1.62819423 |
| 159 | Complement deficiency (HP:0004431) | 1.62732433 |
| 160 | Male infertility (HP:0003251) | 1.62687470 |
| 161 | Bone pain (HP:0002653) | 1.62300616 |
| 162 | Increased connective tissue (HP:0009025) | 1.62068622 |
| 163 | Chondrocalcinosis (HP:0000934) | 1.62016796 |
| 164 | Enlarged penis (HP:0000040) | 1.61936438 |
| 165 | Neoplasm of head and neck (HP:0012288) | 1.61641501 |
| 166 | Esophageal neoplasm (HP:0100751) | 1.61641501 |
| 167 | Atelectasis (HP:0100750) | 1.61566075 |
| 168 | Genu recurvatum (HP:0002816) | 1.60885932 |
| 169 | Abnormality of serum amino acid levels (HP:0003112) | 1.60360126 |
| 170 | Metaphyseal cupping (HP:0003021) | 1.60293727 |
| 171 | Conjunctival hamartoma (HP:0100780) | 1.59471364 |
| 172 | Short humerus (HP:0005792) | 1.59303866 |
| 173 | Myositis (HP:0100614) | 1.58744110 |
| 174 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.58710060 |
| 175 | Deep palmar crease (HP:0006191) | 1.58529695 |
| 176 | Nasal polyposis (HP:0100582) | 1.57827077 |
| 177 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.57524218 |
| 178 | Osteolytic defects of the hand bones (HP:0009699) | 1.57524218 |
| 179 | Germ cell neoplasia (HP:0100728) | 1.56113500 |
| 180 | Gastrointestinal stroma tumor (HP:0100723) | 1.56072018 |
| 181 | Hypophosphatemia (HP:0002148) | 1.55041446 |
| 182 | Short nail (HP:0001799) | 1.54699117 |
| 183 | Spinal cord compression (HP:0002176) | 1.54383786 |
| 184 | Partial duplication of thumb phalanx (HP:0009944) | 1.54300681 |
| 185 | Slender build (HP:0001533) | 1.53428788 |
| 186 | Hyperphosphatemia (HP:0002905) | 1.50865300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.21215486 |
| 2 | TRIB3 | 3.52053897 |
| 3 | PRPF4B | 3.40860782 |
| 4 | LATS2 | 3.36232679 |
| 5 | PKN2 | 2.73228970 |
| 6 | RIPK1 | 2.66198763 |
| 7 | MAP3K11 | 2.60403074 |
| 8 | MAP3K10 | 2.49631518 |
| 9 | ARAF | 2.31897732 |
| 10 | ERN1 | 2.17516146 |
| 11 | NEK2 | 2.09568667 |
| 12 | RIPK4 | 2.09334845 |
| 13 | PIM2 | 2.06113237 |
| 14 | TBK1 | 2.03863782 |
| 15 | MAP3K6 | 1.97884223 |
| 16 | BCKDK | 1.90114696 |
| 17 | TAOK1 | 1.73246513 |
| 18 | STK38L | 1.72242549 |
| 19 | ABL2 | 1.65122561 |
| 20 | PINK1 | 1.64273610 |
| 21 | SIK1 | 1.57650725 |
| 22 | MAP2K2 | 1.56359843 |
| 23 | MST1R | 1.55049762 |
| 24 | SGK3 | 1.53037787 |
| 25 | MAP3K2 | 1.52407554 |
| 26 | BRAF | 1.52204708 |
| 27 | SMG1 | 1.51170242 |
| 28 | LRRK2 | 1.50240477 |
| 29 | KSR2 | 1.48381856 |
| 30 | BMX | 1.45580148 |
| 31 | MARK2 | 1.41952701 |
| 32 | EEF2K | 1.39465060 |
| 33 | DYRK1B | 1.37944438 |
| 34 | IRAK4 | 1.37617310 |
| 35 | PDGFRA | 1.35932249 |
| 36 | MAP4K1 | 1.33546964 |
| 37 | SGK2 | 1.33520102 |
| 38 | ACVR1B | 1.33100779 |
| 39 | PIM1 | 1.32349853 |
| 40 | NTRK3 | 1.29719185 |
| 41 | SGK223 | 1.25594312 |
| 42 | SGK494 | 1.25594312 |
| 43 | CAMKK1 | 1.24542545 |
| 44 | PRKD2 | 1.22449321 |
| 45 | AKT3 | 1.20075202 |
| 46 | ICK | 1.20070276 |
| 47 | JAK3 | 1.19362974 |
| 48 | MAP3K1 | 1.17217423 |
| 49 | GRK6 | 1.15278841 |
| 50 | MAPK12 | 1.13964887 |
| 51 | MAPK11 | 1.12628255 |
| 52 | NEK1 | 1.12534421 |
| 53 | RAF1 | 1.10217674 |
| 54 | CDC42BPA | 1.07630706 |
| 55 | EPHB1 | 1.06416286 |
| 56 | MATK | 1.05517250 |
| 57 | TYK2 | 1.03821295 |
| 58 | MAP3K8 | 1.03515885 |
| 59 | MARK3 | 1.03218113 |
| 60 | EPHB2 | 1.02531043 |
| 61 | CDK7 | 0.99964824 |
| 62 | MAP2K3 | 0.99929712 |
| 63 | STK24 | 0.96904332 |
| 64 | HIPK2 | 0.96723459 |
| 65 | JAK1 | 0.96424337 |
| 66 | TTN | 0.96329616 |
| 67 | STK38 | 0.93106238 |
| 68 | BLK | 0.92384670 |
| 69 | SCYL2 | 0.90003332 |
| 70 | MAP3K13 | 0.89823091 |
| 71 | EPHA2 | 0.89688461 |
| 72 | NEK9 | 0.89106397 |
| 73 | DMPK | 0.88878276 |
| 74 | MAPK7 | 0.87806097 |
| 75 | MAP3K5 | 0.87736569 |
| 76 | FES | 0.85677011 |
| 77 | PLK4 | 0.85195442 |
| 78 | BRSK2 | 0.84598537 |
| 79 | CDK4 | 0.84446705 |
| 80 | RET | 0.84377816 |
| 81 | PRKCH | 0.83144836 |
| 82 | TYRO3 | 0.82357152 |
| 83 | PDGFRB | 0.81340967 |
| 84 | FGFR4 | 0.81165765 |
| 85 | IKBKB | 0.80617864 |
| 86 | MOS | 0.80583635 |
| 87 | MAP3K14 | 0.80230626 |
| 88 | PLK1 | 0.80014089 |
| 89 | UHMK1 | 0.79662577 |
| 90 | STK3 | 0.79637443 |
| 91 | RPS6KA1 | 0.79056599 |
| 92 | RPS6KA4 | 0.78945700 |
| 93 | DDR2 | 0.78735580 |
| 94 | DYRK2 | 0.78500300 |
| 95 | TGFBR1 | 0.77095248 |
| 96 | RPS6KA2 | 0.77031050 |
| 97 | PDK1 | 0.76340160 |
| 98 | PTK6 | 0.76190844 |
| 99 | ILK | 0.75144959 |
| 100 | IKBKE | 0.74319813 |
| 101 | PTK2 | 0.71864861 |
| 102 | STK11 | 0.71812017 |
| 103 | MAP3K9 | 0.71774514 |
| 104 | NTRK1 | 0.70244003 |
| 105 | STK10 | 0.70201895 |
| 106 | LATS1 | 0.69629461 |
| 107 | ALK | 0.69609010 |
| 108 | FGFR3 | 0.68761690 |
| 109 | PIK3CA | 0.68318440 |
| 110 | MAP3K7 | 0.68039285 |
| 111 | IRAK2 | 0.66581623 |
| 112 | IRAK3 | 0.64421860 |
| 113 | TAOK2 | 0.64295080 |
| 114 | CSK | 0.64288945 |
| 115 | ERBB4 | 0.64116362 |
| 116 | NTRK2 | 0.63818582 |
| 117 | ZAP70 | 0.63520438 |
| 118 | SIK2 | 0.62176166 |
| 119 | WEE1 | 0.61290644 |
| 120 | MAP2K4 | 0.61258496 |
| 121 | BUB1 | 0.61192862 |
| 122 | CDK8 | 0.61153533 |
| 123 | CHUK | 0.61081610 |
| 124 | PHKG2 | 0.60321207 |
| 125 | PHKG1 | 0.60321207 |
| 126 | KSR1 | 0.59396819 |
| 127 | CASK | 0.59196915 |
| 128 | DYRK3 | 0.58925841 |
| 129 | TGFBR2 | 0.58414750 |
| 130 | JAK2 | 0.57579921 |
| 131 | CDK19 | 0.57554587 |
| 132 | AURKB | 0.57362400 |
| 133 | OBSCN | 0.57308892 |
| 134 | HCK | 0.56068786 |
| 135 | CAMK4 | 0.55934671 |
| 136 | RPS6KB2 | 0.55872110 |
| 137 | CDK6 | 0.55712172 |
| 138 | CDK12 | 0.55348631 |
| 139 | CHEK2 | 0.55149771 |
| 140 | SGK1 | 0.55073049 |
| 141 | BRSK1 | 0.54073155 |
| 142 | PDPK1 | 0.52668911 |
| 143 | MAP3K3 | 0.52557278 |
| 144 | IRAK1 | 0.51931493 |
| 145 | YES1 | 0.50978094 |
| 146 | RPS6KC1 | 0.50857089 |
| 147 | RPS6KL1 | 0.50857089 |
| 148 | PRKCZ | 0.49026889 |
| 149 | PRKG2 | 0.47103841 |
| 150 | PRKD1 | 0.47056231 |
| 151 | PRKD3 | 0.46413375 |
| 152 | CAMK1 | 0.46093544 |
| 153 | PAK1 | 0.45559749 |
| 154 | RPS6KA6 | 0.45447675 |
| 155 | NLK | 0.43384634 |
| 156 | MTOR | 0.43345058 |
| 157 | PRKCI | 0.42889005 |
| 158 | PRKAA1 | 0.41283740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 3.59009620 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.76785728 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.64739310 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.54772240 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26919963 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.17026918 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.05522138 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04910408 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.99437681 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.69957395 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.67919564 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65651054 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59524931 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.58506724 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.55843523 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.52862475 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51083003 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.50485754 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.48335375 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47579769 |
| 21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.45590333 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45301033 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43487003 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43233444 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43122014 |
| 26 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.41953793 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.38397252 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38088681 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34481027 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33351672 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.31133498 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30114951 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.29891090 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.28178818 |
| 35 | Thyroid cancer_Homo sapiens_hsa05216 | 1.26947093 |
| 36 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.24419423 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22761119 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.22213951 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.19935316 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19705754 |
| 41 | Base excision repair_Homo sapiens_hsa03410 | 1.19592718 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19450484 |
| 43 | DNA replication_Homo sapiens_hsa03030 | 1.18880571 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17255066 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15760870 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.14064007 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13658396 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.13307445 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.13287421 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12984706 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.12541516 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12007245 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11410219 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10038621 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09557129 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08865742 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07430713 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07339196 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06551987 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05156890 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04656771 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03700138 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03669817 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03477720 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03437477 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00936093 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00449261 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.99364933 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98292419 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97727910 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97511104 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97115421 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97103485 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95151536 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 0.93479466 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92828001 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.92007946 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92007632 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.91543882 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.90062768 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89481505 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.88012119 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.87117115 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.86571939 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86398315 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.84877097 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84049084 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83327896 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82729979 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82447672 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81091637 |
| 92 | Cell cycle_Homo sapiens_hsa04110 | 0.80990613 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80977532 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80345125 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79952425 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79365889 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78987545 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78709634 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78643811 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78524451 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78460736 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.78451125 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77872451 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.76988069 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.76816800 |
| 106 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76697065 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76030598 |
| 108 | Melanogenesis_Homo sapiens_hsa04916 | 0.75713165 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.75692915 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.74913707 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74550866 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.74018425 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73566529 |
| 114 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73155729 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72819271 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71130246 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69930395 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69342008 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68693951 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68345160 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68113015 |
| 122 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.68104470 |
| 123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67981695 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67941232 |
| 125 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67852549 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67125847 |
| 127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64622824 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.64268344 |
| 129 | Mismatch repair_Homo sapiens_hsa03430 | 0.63948889 |
| 130 | Influenza A_Homo sapiens_hsa05164 | 0.63942256 |
| 131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63906944 |
| 132 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61902586 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.60926973 |
| 134 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60568617 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59986050 |
| 136 | Spliceosome_Homo sapiens_hsa03040 | 0.59979910 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59764586 |
| 138 | Pertussis_Homo sapiens_hsa05133 | 0.59464493 |
| 139 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59071430 |
| 140 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58896351 |
| 141 | Legionellosis_Homo sapiens_hsa05134 | 0.58434834 |
| 142 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58332260 |
| 143 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57689232 |
| 144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57102055 |
| 145 | Axon guidance_Homo sapiens_hsa04360 | 0.55027974 |
| 146 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54972760 |
| 147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54965359 |
| 148 | Insulin resistance_Homo sapiens_hsa04931 | 0.54411055 |
| 149 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.54090216 |
| 150 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52803462 |
| 151 | Apoptosis_Homo sapiens_hsa04210 | 0.52594720 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51217202 |
| 153 | Bile secretion_Homo sapiens_hsa04976 | 0.50631126 |
| 154 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50314102 |
| 155 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49480539 |
| 156 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49466081 |
| 157 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48014302 |
| 158 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47231071 |
| 159 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46842382 |
| 160 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45493803 |
| 161 | Shigellosis_Homo sapiens_hsa05131 | 0.43839343 |
| 162 | Lysine degradation_Homo sapiens_hsa00310 | 0.43348460 |
| 163 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41797191 |
| 164 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41310695 |
| 165 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41213839 |
| 166 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40667787 |
| 167 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40656228 |
| 168 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40473930 |
| 169 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39517662 |
| 170 | Hepatitis B_Homo sapiens_hsa05161 | 0.39049075 |
| 171 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37105039 |
| 172 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36877005 |
| 173 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36613707 |
| 174 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36202168 |
| 175 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35933902 |
| 176 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35850981 |
| 177 | Prion diseases_Homo sapiens_hsa05020 | 0.34140424 |

